India Approves Baraclude? (entecavir) For Treatment Of Chronic HEPATITIS B
Bristol-Myers Squibb has announced the launch of BARACLUDE? (entecavir) for the treatment of chronic hepatitis B virus infection //following its approval by the Drug Controller General of India. BARACLUDE (entecavir) is indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in...Challenges in Entecavir Drug Treatment
According to a new report in the New England Journal of Medicine,treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. the researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of H...